Körber launches MES for small pharma

Körber on May 18 launched PAS-X Neo, a cloud-native manufacturing execution system for small and mid-sized pharmaceutical and biopharmaceutical companies, at the Pharma Manufacturing World Summit in Boston. The Hamburg-based industrial technology group said the software is meant to help manufacturers move off paper-based or fragmented shop-floor processes with a lower-cost, lower-complexity entry point than traditional MES rollouts. The product adds to Körber’s PAS-X portfolio, which already includes its flagship PAS-X MES platform and related software offerings. Körber said PAS-X Neo is aimed at companies and sites with limited internal IT, validation and MES resources. ### Why did Körber build a separate MES for smaller drugmakers? Körber said many smaller pharmaceutical and biopharmaceutical manufacturers still run production with paper records or disconnected systems, which can increase manual errors and compliance risk. In its May 18 announcement, the company said PAS-X Neo was purpose-built for small and mid-sized companies and sites that need a faster route into digital manufacturing without the heavier implementation burden associated with larger enterprise systems. (koerber-pharma.com) Oliver Weber, executive vice president of software in Körber’s Pharma business, said the company wants to make “enterprise-grade innovation accessible” to smaller manufacturers. Pierrick Lebigre, vice president of product for software in the same unit, said digitalization in pharma should not be “an all or nothing decision,” describing PAS-X Neo as a first step into MES-based operations. (koerber-pharma.com) ### What does PAS-X Neo actually promise on implementation? Körber said the software is designed to be implemented in less than two months using standardized templates, minimal configuration and AI support. The company described the architecture as lean, standardized and cloud native, with what it called essential GMP functionality built in from the start. (koerber-pharma.com) Microsoft said in a separate customer case study published this month that Körber has been moving its PAS-X MES offering toward software-as-a-service delivery on Microsoft Azure to reduce capital and resource requirements for customers. That broader cloud push provides context for PAS-X Neo’s positioning as a lighter-weight deployment model for manufacturers that want scalable MES capabilities without a large IT footprint. (koerber-pharma.com) ### Which compliance requirements did Körber say are built in? Körber said PAS-X Neo includes support for ALCOA+ data integrity principles, FDA 21 CFR Part 11, EU Annex 11, audit trails and electronic signatures from day one. Those are core controls for regulated pharmaceutical manufacturing, where batch documentation, operator actions and record integrity must be captured in a way that can support GMP compliance. (microsoft.com) Körber’s PAS-X product materials say the broader PAS-X MES suite is used across pharmaceutical, biotech and cell and gene therapy manufacturing to control, monitor and document production processes digitally and in real time. The company also says it can integrate with surrounding IT systems through standard interfaces, positioning PAS-X Neo as an entry point into that wider software ecosystem. (koerber-pharma.com) ### Why does this matter beyond software buyers? William Blair analysts said in an April 10 report, cited by Pharma Manufacturing, that demand from smaller biopharma innovators could rebound in 2026 as funding conditions improve. That matters because smaller manufacturers are more likely to need lower-cost digital systems as they scale development and production activities. (koerber-pharma.com) For procurement and operations teams, a formal MES can also change how production inputs are qualified and documented. Körber did not spell out specific purchasing changes in its announcement, but the compliance features it highlighted—audit trails, electronic signatures and standardized digital records—are the types of controls that can affect how manufacturers document the use of validated consumables, components and other quality-critical shop-floor items. This is an inference based on the stated compliance functions of MES systems and Körber’s description of PAS-X Neo. (pharmamanufacturing.com) ### Where does PAS-X Neo sit in Körber’s broader strategy? Körber said PAS-X Neo extends a software lineup that includes PAS-X MES, PAS-X Savvy and AI offerings, while giving customers a way to start small and scale later. The company says its broader PAS-X MES suite supports cloud deployments through AWS and Microsoft Azure, including fully managed software-as-a-service options. (koerber-pharma.com) The next public milestone is commercial uptake after the Boston launch. Körber introduced PAS-X Neo during the May 18-20 Pharma Manufacturing World Summit, and the product is now listed in the company’s press materials and PAS-X software portfolio. (koerber-pharma.com)